Video
Dr. Ben Chew discusses kidney stones and metabolic syndrome
Author(s):
"Treat the patient as a whole, not just as a stone former," Chew advises.
In this interview, Ben H. Chew, MD, MSc, associate professor of urologic sciences at the University of British Columbia, Vancouver, discusses findings from the recent Journal of Endourology paper, “Metabolic Syndrome Negatively Impacts Stone-Specific Quality of Life,” for which he served as a study author.
More videos:
Dried cranberry powder shows promise in overactive bladder
Dr. Michael Albo discusses female urology training fellowships
Botulinum toxin benefits patients with adult neurogenic lower urinary tract dysfunction
Related Videos
Investigators evaluate tamsulosin use in pediatric patients
Pain management disparities in kidney stones point to need for guidelines, experts say
Perry Xu, MD, on the potential of AI in the endourology space
Kate H. Kraft, MD, discusses pre-op tamsulosin use in pediatric patients undergoing URS
Study findings point to disparities in pain management for kidney stones
Christina Ching, MD, on overcoming barriers to follow-up after pediatric stone surgery
Christina Ching, MD, on predictors of follow-up after pediatric stone surgery
Christina Ching, MD, on study of follow-up after pediatric stone surgery
Marcelino Rivera, MD, on potential future advancements in stone disease, BPH
Future directions and research on the CVAC System for kidney stones
Related Content
